GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Total Liabilities

Incanthera (AQSE:INC) Total Liabilities : £0.83 Mil (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Incanthera Total Liabilities?

Incanthera's Total Liabilities for the quarter that ended in Sep. 2023 was £0.83 Mil.

Incanthera's quarterly Total Liabilities increased from Sep. 2022 (£0.20 Mil) to Mar. 2023 (£0.41 Mil) and increased from Mar. 2023 (£0.41 Mil) to Sep. 2023 (£0.83 Mil).

Incanthera's annual Total Liabilities increased from Mar. 2021 (£0.17 Mil) to Mar. 2022 (£0.20 Mil) and increased from Mar. 2022 (£0.20 Mil) to Mar. 2023 (£0.41 Mil).


Incanthera Total Liabilities Historical Data

The historical data trend for Incanthera's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera Total Liabilities Chart

Incanthera Annual Data
Trend Mar20 Mar21 Mar22 Mar23
Total Liabilities
0.18 0.17 0.20 0.41

Incanthera Semi-Annual Data
Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Total Liabilities Get a 7-Day Free Trial 0.24 0.20 0.20 0.41 0.83

Incanthera Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Incanthera's Total Liabilities for the fiscal year that ended in Mar. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.28+(0.131+-5.5511151231258E-17
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=0.41

Total Liabilities=Total Assets (A: Mar. 2023 )-Total Equity (A: Mar. 2023 )
=0.197--0.214
=0.41

Incanthera's Total Liabilities for the quarter that ended in Sep. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.633+(0.195+-5.5511151231258E-17
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=0.83

Total Liabilities=Total Assets (Q: Sep. 2023 )-Total Equity (Q: Sep. 2023 )
=0.161--0.667
=0.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Incanthera Total Liabilities Related Terms

Thank you for viewing the detailed overview of Incanthera's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Incanthera (AQSE:INC) Business Description

Traded in Other Exchanges
N/A
Address
76 King Street, Manchester, GBR, M2 4NH
Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera (AQSE:INC) Headlines

No Headlines